Published in J Virol on September 01, 2003
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol (2007) 2.53
Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology (2011) 1.53
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med (2005) 1.26
Feeling manipulated: cytomegalovirus immune manipulation. Virol J (2009) 1.19
Human cytomegalovirus interleukin-10 polarizes monocytes toward a deactivated M2c phenotype to repress host immune responses. J Virol (2013) 0.98
CD4 CTL: living up to the challenge. Semin Immunol (2013) 0.93
Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation. J Virol (2006) 0.87
Giving CD4+ T cells the slip: viral interference with MHC class II-restricted antigen processing and presentation. Curr Opin Immunol (2016) 0.77
The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 8.25
Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (1996) 7.90
The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature (2001) 7.59
A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology (1988) 4.72
Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med (2002) 4.33
Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A (2000) 3.45
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol (2000) 3.30
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A (1996) 3.16
Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur J Immunol (1982) 3.12
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell (1999) 2.97
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity (1997) 2.93
Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J Virol (1995) 2.87
Directed egress of animal viruses promotes cell-to-cell spread. J Virol (2002) 2.72
Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity (2000) 2.53
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med (1998) 2.49
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity (1997) 2.45
A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest (2001) 2.36
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med (2003) 2.20
Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J Cell Biol (1998) 2.16
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A (1997) 2.14
HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci U S A (2001) 2.14
HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol (1990) 2.12
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med (1999) 2.08
Live and let die: Nef functions beyond HIV replication. Immunity (2002) 1.64
Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol (2000) 1.60
Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci U S A (2001) 1.60
Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity (2000) 1.54
Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr Opin Microbiol (2002) 1.52
Association between HLA-DM and HLA-DR in vivo. Immunity (1996) 1.34
The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J Virol (2002) 1.28
Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J Biol Chem (2001) 1.27
Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol (2002) 1.25
Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J Virol (2001) 1.21
Clonotypic structure of the human CD4+ memory T cell response to cytomegalovirus. J Immunol (2001) 1.19
MHC class II-restricted antigen processing and presentation. Adv Immunol (2000) 1.16
Viral inhibition of MHC class II antigen presentation. Trends Immunol (2003) 1.16
Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol (2000) 1.14
Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells. J Virol (2002) 1.08
Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression. J Virol (1999) 1.07
Human cytomegalovirus protein US2 interferes with the expression of human HFE, a nonclassical class I major histocompatibility complex molecule that regulates iron homeostasis. J Virol (2001) 1.05
Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J Virol (2002) 1.01
Human cytomegalovirus disrupts constitutive MHC class II expression. J Immunol (2002) 0.99
Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus. Curr Top Microbiol Immunol (2002) 0.98
Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties. J Virol (2003) 0.96
Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells. Gene Ther (2002) 0.92
Adenovirus vectors for human gene therapy. Adv Virus Res (2000) 0.92
Dendritic cells transduced with HIV Nef express normal levels of HLA-A and HLA-B class I molecules. J Acquir Immune Defic Syndr (2001) 0.85
Development and characterization of a binary gene expression system based on bacteriophage T7 components in adenovirus vectors. Gene (1997) 0.80
Novel centrifugal method for simple and highly efficient adenovirus-mediated green fluorescence protein gene transduction into human monocyte-derived dendritic cells. J Immunol Methods (2001) 0.78
Preventing the return of fear in humans using reconsolidation update mechanisms. Nature (2009) 5.82
Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol (2007) 2.53
Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol (2006) 2.45
Integration of global SNP-based mapping and expression arrays reveals key regions, mechanisms, and genes important in the pathogenesis of multiple myeloma. Blood (2006) 2.43
Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma. Blood (2012) 2.38
A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood (2010) 2.25
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J Exp Med (2003) 2.20
Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane. Proc Natl Acad Sci U S A (2007) 2.07
HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell type-specific receptors. Proc Natl Acad Sci U S A (2008) 1.79
Altered fear learning across development in both mouse and human. Proc Natl Acad Sci U S A (2012) 1.77
Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J Virol (2008) 1.64
Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm. J Virol (2003) 1.63
A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol (2009) 1.63
Cytoplasmic residues of herpes simplex virus glycoprotein gE required for secondary envelopment and binding of tegument proteins VP22 and UL11 to gE and gD. J Virol (2006) 1.46
Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread. J Virol (2006) 1.39
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res (2010) 1.39
Investigation of the origin of tensile stress-induced rate enhancements in the photochemical degradation of polymers. J Am Chem Soc (2004) 1.39
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci U S A (2005) 1.38
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood (2010) 1.36
Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons. J Virol (2008) 1.36
Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma. Blood (2013) 1.35
The extracellular domain of herpes simplex virus gE is indispensable for efficient cell-to-cell spread: evidence for gE/gI receptors. J Virol (2005) 1.31
Herpes simplex virus capsids are transported in neuronal axons without an envelope containing the viral glycoproteins. J Virol (2006) 1.28
Herpesvirus gB-induced fusion between the virion envelope and outer nuclear membrane during virus egress is regulated by the viral US3 kinase. J Virol (2009) 1.27
Endogenous human cytomegalovirus gB is presented efficiently by MHC class II molecules to CD4+ CTL. J Exp Med (2005) 1.26
Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J Virol (2002) 1.25
Redistribution of cellular and herpes simplex virus proteins from the trans-golgi network to cell junctions without enveloped capsids. J Virol (2004) 1.24
Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J Virol (2011) 1.23
Deletions of CDKN2C in multiple myeloma: biological and clinical implications. Clin Cancer Res (2008) 1.19
Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol (2009) 1.19
The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins. J Biol Chem (2006) 1.17
Herpes simplex virus gE/gI expressed in epithelial cells interferes with cell-to-cell spread. J Virol (2003) 1.17
Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells. Blood (2013) 1.16
Viral inhibition of MHC class II antigen presentation. Trends Immunol (2003) 1.16
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine (2011) 1.13
Human cytomegalovirus entry into cells. Curr Opin Virol (2012) 1.12
PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway. PLoS Pathog (2012) 1.10
Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol (2009) 1.08
A herpes simplex virus gD-YFP fusion glycoprotein is transported separately from viral capsids in neuronal axons. J Virol (2007) 1.05
Inhibition of TCR signaling by herpes simplex virus. J Immunol (2006) 1.03
Anterograde transport of herpes simplex virus capsids in neurons by both separate and married mechanisms. J Virol (2011) 1.02
HCMV gB shares structural and functional properties with gB proteins from other herpesviruses. Virology (2012) 1.01
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol (2011) 1.01
Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J Virol (2002) 1.01
Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein. MBio (2013) 0.98
Herpes simplex virus membrane proteins gE/gI and US9 act cooperatively to promote transport of capsids and glycoproteins from neuron cell bodies into initial axon segments. J Virol (2012) 0.97
Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties. J Virol (2003) 0.96
Low-pH-dependent changes in the conformation and oligomeric state of the prefusion form of herpes simplex virus glycoprotein B are separable from fusion activity. J Virol (2011) 0.95
Improved risk stratification in myeloma using a microRNA-based classifier. Br J Haematol (2013) 0.95
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance. Blood (2014) 0.94
Fusion between perinuclear virions and the outer nuclear membrane requires the fusogenic activity of herpes simplex virus gB. J Virol (2009) 0.93
Telluride misfit layer compounds: [(PbTe)1.17]m(TiTe₂)n. Angew Chem Int Ed Engl (2014) 0.92
Silica and noise exposure during installation of fibercement siding. J Occup Environ Hyg (2004) 0.91
Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients. Haematologica (2011) 0.87
Accuracy of intra-articular glenohumeral injections: the anterosuperior technique with arthroscopic documentation. Arthroscopy (2011) 0.87
Synthesis of inorganic structural isomers by diffusion-constrained self-assembly of designed precursors: a novel type of isomerism. Angew Chem Int Ed Engl (2014) 0.82
Hyperconcavity of the lumbar vertebral endplates in the elite football lineman. Am J Sports Med (2004) 0.81
Bringing bike share to a low-income community: lessons learned through community engagement, Minneapolis, Minnesota, 2011. Prev Chronic Dis (2013) 0.80
The synthesis of [(Bi2Te3)x{(TiTe2)y}1.36] superlattices from modulated elemental reactants. J Am Chem Soc (2005) 0.80
Designed synthesis, structure, and properties of a family of ferecrystalline compounds [(PbSe)(1.00)](m)(MoSe2)(n). J Am Chem Soc (2013) 0.79
Suppressing a charge density wave by changing dimensionality in the ferecrystalline compounds ([SnSe]1.15)1(VSe2)n with n = 1, 2, 3, 4. Nano Lett (2015) 0.78
One- versus two-incision technique for distal biceps tendon repair. HSS J (2008) 0.78
Synthesis of the new metastable skutterudite compound NiSb(3) from modulated elemental reactants. Inorg Chem (2002) 0.77
A seek-and-hide game between Cd1-restricted T cells and herpesviruses. J Clin Invest (2005) 0.77
Synthesis and structural evolution of rusb3, a new metastable skutterudite compound. Inorg Chem (2004) 0.77
A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue. Leuk Lymphoma (2014) 0.76
Corrosion Resistance of Atomic Layer Deposition-Generated Amorphous Thin Films. ACS Appl Mater Interfaces (2016) 0.75
Solid-state chemistry: New order for lithium bromide. Nature (2008) 0.75
Controlling size-induced phase transformations using chemically designed nanolaminates. Angew Chem Int Ed Engl (2013) 0.75
Preparation, formation, and structure of [(SnSe)1.04]m(MoSe2)n intergrowth compounds (0 < m and n < 32) from designed precursors. Inorg Chem (2014) 0.75
Clinical crown length of the maxillary anterior teeth preorthodontics and postorthodontics. J Periodontol (2007) 0.75
Synthesis of crystalline skutterudite superlattices using the modulated elemental reactant method. J Am Chem Soc (2003) 0.75
The importance of entering cells, non-trivial solutions for serious viruses. Curr Opin Virol (2012) 0.75
Charge transfer vs. dimensionality: what affects the transport properties of ferecrystals? Nanoscale (2015) 0.75
Design and synthesis of [(Bi2Te3)x(TiTe2)y] superlattices. Angew Chem Int Ed Engl (2003) 0.75
Raman spectroscopy insights into the size-induced structural transformation in SnSe nanolayers. Langmuir (2014) 0.75
Meniscal Repair in the Setting of Revision Anterior Cruciate Ligament Reconstruction: Results From the MARS Cohort. Am J Sports Med (2020) 0.75
Suppression of binary nucleation in amorphous La-Fe-Sb mixtures. J Am Chem Soc (2003) 0.75
Size-dependent structural distortions in one-dimensional nanostructures. Angew Chem Int Ed Engl (2013) 0.75